Cite

HARVARD Citation

    Castilla-Rodríguez, I. et al. (n.d.). Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain. Expert opinion on orphan drugs. pp. 567-575. [Online]. 
  
Back to record